Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.

European Urology
Laurence KlotzMasoom A Haider

Abstract

This study aimed to determine, in men recently diagnosed with grade group 1 (GG1) prostate cancer, if magnetic resonance imaging (MRI) with targeted biopsy could identify a greater proportion of men with GG ≥2 cancer on their confirmatory biopsy compared with systematic biopsies. The study was registered with www.clinicaltrials.gov (NCT01354171). This study is a prospective, randomized, multicenter, open-label trial. Eligible patients were men diagnosed with GG1 cancer within 1 yr prior to study entry in whom a confirmatory biopsy was indicated. Patients were randomized to 12-core systematic biopsy or MRI with systematic and targeted biopsy using the Artemis fusion targeting system. The primary end point was the proportion upgraded to GG ≥2 in each arm. In total, 296 men were registered and 273 randomized. Of the MRI group, 64% had a region of interest. No difference was observed in the rate of GG ≥2 upgrading (the intent-to-treat population, p=0.7, and per-protocol [PP] population, p=0.4), GG ≥2 upgrading within each stratum separately, or GG ≥3. After central pathology review, upgrading was observed in 36/132 (27%) men in the systematic biopsy arm and 42/127 (33%) men in the MRI arm (p=0.3). Upgrading was seen in 19/137 (14%)...Continue Reading

Associated Clinical Trials

Citations

Feb 12, 2019·BJU International·Allison S Glass, Marc A Dall'Era
Jan 24, 2020·The British Journal of Radiology·Nikita SushentsevTristan Barrett
Mar 5, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel W LinLisa F Newcomb
Mar 5, 2020·The New England Journal of Medicine·Michael AhdootPeter A Pinto
Apr 27, 2019·Nature Reviews. Cancer·Sudhir SrivastavaBarnett S Kramer
Apr 11, 2020·Expert Review of Medical Devices·Luke O'ConnorBaris Turkbey
Dec 13, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott E EggenerHimisha Beltran
Oct 24, 2019·Current Opinion in Urology·Joseph M NorrisVeeru Kasivisvanathan
Jun 26, 2020·World Journal of Urology·Luke P O'ConnorBaris Turkbey
Jan 5, 2021·World Journal of Urology·Richard C WuArvin K George
Nov 3, 2020·Investigative and Clinical Urology·Tae Un KimSung Woo Park
Dec 9, 2020·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Joseba SalgueroMaría José Requena
Feb 17, 2021·World Journal of Urology· Banerjee, Sanoj Punnen
Nov 16, 2020·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Q VesvalJ Olivier
Mar 4, 2021·World Journal of Urology·Colton H WalkerTodd M Morgan
Mar 24, 2021·Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica·Vito LaceteraValerio Beatrici
Apr 16, 2021·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Chau Hung LeeCher Heng Tan
Oct 4, 2020·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·G FiardC M Moore
Jul 15, 2021·Nature Cancer·Joaquin MateoHimisha Beltran
Aug 17, 2021·Radiologia brasileira·Olayemi Atinuke AlagbeValdair Francisco Muglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.